POLYPEPTIDE LABORATORIES A/S: Financial statements 2019
CVR: 19056201
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
POLYPEPTIDE LABORATORIES A/S (CVR 19056201) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 24,000 and a net result of DKK -824,000 compared with DKK -1,482,000 the year before. Equity in the 2019 report amounted to DKK 65,176,000. The solvency ratio was 99.9%.
- Gross Profit
- DKK 24,000
- Profit/Loss
- DKK -824,000
- Equity
- DKK 65,176,000
- Total Assets
- DKK 65,210,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 24 t. | -824 t. | 65.2 mio. | - |
| 2018 | - | 0 | -1.5 mio. | 66 mio. | - |
| 2017 | - | 721 t. | -757 t. | 67.5 mio. | 0 |
| 2016 | - | 15.2 mio. | -3.3 mio. | 68.2 mio. | 12000 |
| 2015 | - | - | -9.5 mio. | 64.9 mio. | 31 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
POLYPEPTIDE LABORATORIES A/S has published its annual report for 2018. Gross profit came to DKK 0, and the net result was DKK -1,482,000.
About POLYPEPTIDE LABORATORIES A/S
POLYPEPTIDE LABORATORIES A/S is a Danish company of the type Aktieselskab based in Hillerød, founded in 1996. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named A/S PSE NR. 4948. The management consists of Raoul Bernhardt. The board consists of Juan José Gonzalez Casanova (chair), Christina Ellen Del Vecchio and Raoul Bernhardt. The company is owned by PolyPeptide Laboratories Holding (PPL) AB. The company has 0 employees (2017). In 2025, the company reported a net result of DKK 2,632,000 compared with DKK 7,060,000 the year before. Equity in the 2025 report amounted to DKK 75,499,000.